Ardana Bioscience Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 2000-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.ardana.co.uk
Clinical Trials
11
Active:8
Completed:2
Trial Phases
2 Phases
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (66.7%)Phase 2
1 (33.3%)Study of 3 Doses of ARD-0403 in Testosterone Deficient Men
Phase 2
Completed
- Conditions
- Hypogonadism
- First Posted Date
- 2008-01-17
- Last Posted Date
- 2008-01-17
- Lead Sponsor
- Ardana Bioscience Ltd
- Target Recruit Count
- 42
- Registration Number
- NCT00597051
- Locations
- 🇧🇾
Republican Endocrinology Center Hospital, Minsk, Belarus
Open-Label Study of ARD-0403 in Testosterone Deficient Men
Phase 3
Terminated
- Conditions
- Hypogonadism
- First Posted Date
- 2007-11-22
- Last Posted Date
- 2008-04-01
- Lead Sponsor
- Ardana Bioscience Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT00562731
- Locations
- 🇺🇸
Medical Affiliated Research Center, Inc, Huntsville, Alabama, United States
🇺🇸Stanford University, Stanford, California, United States
🇺🇸Harbor-UCLA Medical Center, Torrance, California, United States
Open-Label Study of ARD-0403 in Testosterone Deficient Men
Phase 3
Completed
- Conditions
- Hypogonadism
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2008-04-18
- Lead Sponsor
- Ardana Bioscience Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT00448955
- Locations
- 🇺🇸
Medical Affiliated Research Center, Inc, Huntsville, Alabama, United States
🇺🇸Stanford University, Stanford, California, United States
🇺🇸Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, California, United States
News
No news found